Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-056110
Filing Date
2020-05-04
Accepted
2020-05-04 14:18:27
Documents
1
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2018429-2_form4.html 4  
1 FORM 4 tm2018429-2_form4.xml 4 3294
  Complete submission text file 0001104659-20-056110.txt   4828
Mailing Address
Business Address
GOLDSTEIN DOV A MD (Reporting) CIK: 0001120478 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 20844138

Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations